| 000 | 01613 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517193944.0 | ||
| 264 | 0 | _c20181018 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a2374-4243 | ||
| 024 | 7 |
_a10.1080/23744235.2018.1423703 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNi, Wentao | |
| 245 | 0 | 0 |
_aUse of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae. _h[electronic resource] |
| 260 |
_bInfectious diseases (London, England) _c07 2018 |
||
| 300 |
_a507-513 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aBacterial Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKlebsiella Infections _xblood |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMinocycline _xadverse effects |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 | _aMonte Carlo Method |
| 650 | 0 | 4 |
_aPneumonia, Bacterial _xblood |
| 650 | 0 | 4 |
_aSputum _xmicrobiology |
| 650 | 0 | 4 | _aTigecycline |
| 650 | 0 | 4 |
_abeta-Lactamases _xbiosynthesis |
| 700 | 1 | _aLi, Guobao | |
| 700 | 1 | _aZhao, Jin | |
| 700 | 1 | _aCui, Junchang | |
| 700 | 1 | _aWang, Rui | |
| 700 | 1 | _aGao, Zhancheng | |
| 700 | 1 | _aLiu, Youning | |
| 773 | 0 |
_tInfectious diseases (London, England) _gvol. 50 _gno. 7 _gp. 507-513 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/23744235.2018.1423703 _zAvailable from publisher's website |
| 999 |
_c27963422 _d27963422 |
||